Janus Henderson Investors US’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Janus Henderson Investors US's GILD Position: Q1 2017 in Review
Janus Henderson Investors US reduced its Gilead Sciences (GILD) stake by 29% in Q1 2017, selling an estimated $38.8M and leaving 1,370,698 shares worth $93.1M. The position accounts for 0.08% of the portfolio, ranked #297.
Janus Henderson Investors US first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.52B in Q1 2014. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.
- Janus Henderson Investors US held 1,370,698 shares of Gilead Sciences worth $93.1M as of Q1 2017.
- Janus Henderson Investors US sold 551,205 Gilead Sciences shares in Q1 2017, an estimated $38.8M.
- Gilead Sciences made up 0.08% of Janus Henderson Investors US's portfolio in Q1 2017, its #297 holding.
- Janus Henderson Investors US first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Gilead Sciences position peaked at $1.52B in Q1 2014.
- 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.